Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...
An Argentinian colleague recently posed a rather blunt question to me: “How, pray tell, does your beloved European Union help you and me?” Her doubts are valid. Given the bureaucratic immensity of the ...